Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.
1 other identifier
observational
50
1 country
2
Brief Summary
The purpose of this study is to describe the impact of the iFuse Bedrock technique to decrease post-operative pains in patients who underwent multilevel posterior lumbosacral fusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2022
CompletedFirst Posted
Study publicly available on registry
March 11, 2022
CompletedStudy Start
First participant enrolled
June 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedNovember 8, 2024
November 1, 2024
3.8 years
February 21, 2022
November 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in self-reported Oswestry Disability Index (ODI) at 12 months
A decrease of 16 points in the ODI score at 12 months compared to the preoperative score is expected in order to demonstrate a 30% effecacy of the iFuse Bedrock technique in reducing postoperative pain.
12 months
Secondary Outcomes (14)
Change from baseline in sacroiliac joint pain provocation tests.
During 12 months
Assessment of the Oswestry Disability Index
3 and 6 months
Improvement of back and leg pains at 3, 6 and 12 months compared to preoperative scores
3, 6 and 12 months
Change in Patient's quality of life
3, 6 and 12 months
Proportion of subjects with postoperative SIJ fusion failure
12 months
- +9 more secondary outcomes
Study Arms (1)
iFuse Bedrock technique
Multilevel lumbar fusion procedure with additional sacroiliac joint stabilization using the iFuse-3D system
Interventions
Lumbosacral arthrodesis on 2 or more spinal segments (including at least L4, L5 and S1 vertebrae) associated with a sacroiliac fusion procedure according to the Bedrock technique using the iFuse 3D system and iliac fixation.
Eligibility Criteria
All participants enrolled in the study are adult subjects who underwent an open posterior lumbosacral fusion procedure with additional sacroiliac joint fusion according to the iFuse Bedrock technique (insertion of the iFUSE-3D implant). Lumbosacral fusion involved at least the following vertebrae : L4, L5 and S1.
You may qualify if:
- Subject scheduled for open posterior lumbosacral arthrodesis (including at least the following three vertebrae: L4, L5 and S1) associated with a sacroiliac fusion procedure and iliac fixation (thoracolumbar fusion procedures extended to sacrum are eligible in the study);
- Insertion of at least 1 iFuse-3D implant according to the iFuse Bedrock technique (uni- and bilateral insertion are eligible);
- Subject who preoperatively responded positively to pain provocation tests for SIJ dysfunction with or without a positive SIJ infiltration test;
- Patient with a degenerative sacroiliac joint disease requested a fusion procedure;
You may not qualify if:
- Major osteoporosis (DEXA scan \> 3);
- Any previous history of sacroiliac joint fusion or any surgical procedure involving a S2-iliac fusion;
- Subjects requested a SIJ fusion without the iFuse-3D device or iFuse-3D not inserted according to the manufacturer instruction (Bedrock technique);
- Subjects with a medical or surgical contraindication preventing the intervention from being performed or potentially interfering in the interpretation of the data collected (neurologic condition, local or systemic infection, any known allergy to surgical implants, psychiatric diseases, ...);
- Currently pregnant or planning pregnancy;
- Prisoner or a ward of the state;
- Subject no willing to participate in the study;
- Subject not affiliated to a social security insurance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Polyclinique Bordeaux Nord Aquitainelead
- SI-BONE, Inc.collaborator
Study Sites (2)
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, 33300, France
Hôpitaux Universitaires de Marseille
Marseille, 13005, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Charles Le Huec, M.D., PhD
VERTEBRA Institute, Polyclinique Bordeaux Nord Aquitaine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2022
First Posted
March 11, 2022
Study Start
June 10, 2022
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
November 8, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share